durvalumab,Tremelimumab
AstraZeneca
astrazeneca shares data at easl and esmo world gi for imfinzi combinations in patients with liver and biliary tract cancers $azn 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice